Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Oct;84(4 Pt 2):640-5; discussion 645-7.
doi: 10.1016/0091-6749(89)90203-0.

Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin

Affiliations
Clinical Trial

Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin

A P Knutsen. J Allergy Clin Immunol. 1989 Oct.

Abstract

Selective IgG subclass deficiencies and/or selectively impaired antibody responses to bacterial capsular polysaccharide antigens have been increasingly reported. In this report, 13 children with recurrent infections and deficient antibody responses to polysaccharide antigens are described. Serum IgG2 subclass concentrations were normal in all the patients, and two children had low IgG3 levels. Mean serum antibody concentrations to the capsular polysaccharide antigens of Streptococcus pneumoniae and Haemophilus influenzae were significantly decreased after immunizations, but antibody responses to diphtheria and tetanus toxoids were normal. The identification of children with selective antibody deficiencies and recurrent infections has prompted a multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous immune globulin therapy in these patients.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources